185 related articles for article (PubMed ID: 33014430)
1. EDIL3 promotes epithelial-mesenchymal transition and paclitaxel resistance through its interaction with integrin α
Gasca J; Flores ML; Jiménez-Guerrero R; Sáez ME; Barragán I; Ruíz-Borrego M; Tortolero M; Romero F; Sáez C; Japón MA
Cell Death Discov; 2020; 6():86. PubMed ID: 33014430
[TBL] [Abstract][Full Text] [Related]
2. Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation.
Feng MX; Ma MZ; Fu Y; Li J; Wang T; Xue F; Zhang JJ; Qin WX; Gu JR; Zhang ZG; Xia Q
Mol Cancer; 2014 Oct; 13():226. PubMed ID: 25273699
[TBL] [Abstract][Full Text] [Related]
3. EDIL3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma.
Xia H; Chen J; Shi M; Gao H; Sekar K; Seshachalam VP; Ooi LL; Hui KM
J Hepatol; 2015 Oct; 63(4):863-73. PubMed ID: 25980764
[TBL] [Abstract][Full Text] [Related]
4. EDIL3 regulates gastric cancer cell migration, invasion and epithelial-mesenchymal transition via TGF-β1/XIST/miR-137 feedback loop.
Zhang L; Peng KW; Wang B; Yang XF; Zhang ZM
Transl Cancer Res; 2020 Oct; 9(10):6313-6330. PubMed ID: 35117240
[TBL] [Abstract][Full Text] [Related]
5. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
6. EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint Blockade.
Tabasum S; Thapa D; Giobbie-Hurder A; Weirather JL; Campisi M; Schol PJ; Li X; Li J; Yoon CH; Manos MP; Barbie DA; Hodi FS
Cancer Immunol Res; 2023 Nov; 11(11):1493-1507. PubMed ID: 37728484
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of EDIL3 Expression and Correlation with Mesenchymal Phenotype and Microvessel Density in Lung Adenocarcinoma.
Jeong D; Ban S; Oh S; Jin Lee S; Yong Park S; Koh YW
Sci Rep; 2017 Aug; 7(1):8649. PubMed ID: 28819306
[TBL] [Abstract][Full Text] [Related]
8. EDIL3 depletion suppress epithelial-mesenchymal transition of lens epithelial cells
Zhang R; Wei YH; Zhao CY; Song HY; Shen N; Cui X; Gao X; Qi ZT; Zhong M; Shen W
Int J Ophthalmol; 2018; 11(1):18-24. PubMed ID: 29375985
[TBL] [Abstract][Full Text] [Related]
9. Tumor derived EDIL3 modulates the expansion and osteoclastogenesis of myeloid derived suppressor cells in murine breast cancer model.
Kun Z; Xin G; Tao W; Chenglong Z; Dongsheng W; Liang T; Tielong L; Jianru X
J Bone Oncol; 2019 Jun; 16():100238. PubMed ID: 31110935
[TBL] [Abstract][Full Text] [Related]
10. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
[TBL] [Abstract][Full Text] [Related]
11. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin.
M Brandão-Costa R; Helal-Neto E; M Vieira A; Barcellos-de-Souza P; Morgado-Diaz J; Barja-Fidalgo C
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340328
[TBL] [Abstract][Full Text] [Related]
12. Epidermal Growth Factor (EGF)-Like Repeats and Discoidin I-Like Domains 3 (EDIL3): A Potential New Therapeutic Tool for the Treatment of Keloid Scars.
Ryu YH; Lee YJ; Kim KJ; Lee SJ; Han YN; Rhie JW
Tissue Eng Regen Med; 2017 Jun; 14(3):267-277. PubMed ID: 30603483
[TBL] [Abstract][Full Text] [Related]
13. EDIL3 influenced the αvβ3-FAK/MEK/ERK axis of endothelial cells in psoriasis.
Niu X; Han Q; Li X; Li J; Liu Y; Li Y; Wu Y; Zhang K
J Cell Mol Med; 2022 Oct; 26(20):5202-5212. PubMed ID: 36065978
[TBL] [Abstract][Full Text] [Related]
14. The extracellular matrix protein Edil3 stimulates osteoblast differentiation through the integrin α5β1/ERK/Runx2 pathway.
Oh SH; Kim JW; Kim Y; Lee MN; Kook MS; Choi EY; Im SY; Koh JT
PLoS One; 2017; 12(11):e0188749. PubMed ID: 29182679
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells.
Han ML; Zhao YF; Tan CH; Xiong YJ; Wang WJ; Wu F; Fei Y; Wang L; Liang ZQ
Acta Pharmacol Sin; 2016 Dec; 37(12):1606-1622. PubMed ID: 27840408
[TBL] [Abstract][Full Text] [Related]
16. Differential Effects of Integrin
Stojanović N; Dekanić A; Paradžik M; Majhen D; Ferenčak K; Ruščić J; Bardak I; Supina C; Tomicic MT; Christmann M; Osmak M; Ambriović-Ristov A
Mol Pharmacol; 2018 Dec; 94(6):1334-1351. PubMed ID: 30262596
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic and immunological role of EDIL3 in human tumours: From pan-cancer analysis to validation in gastric cancer.
Ke B; Jin P; Wang XJ; Liu N; Liang H; Zhang RP
Heliyon; 2024 Jun; 10(11):e32291. PubMed ID: 38882287
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells.
Mori S; Kodaira M; Ito A; Okazaki M; Kawaguchi N; Hamada Y; Takada Y; Matsuura N
PLoS One; 2015; 10(9):e0137486. PubMed ID: 26334633
[TBL] [Abstract][Full Text] [Related]
19. Psoriasis-associated angiogenesis is mediated by EDIL3.
Niu X; Han Q; Liu Y; Li J; Hou R; Li J; Zhang K
Microvasc Res; 2020 Nov; 132():104056. PubMed ID: 32795468
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1b Splice Variant Promotes αvβ3-mediated EMT Induced by LPS in Breast Cancer Cells.
Luo BP; Luo J; Hu YB; Yao XW; Wu FH
Curr Med Sci; 2018 Jun; 38(3):467-472. PubMed ID: 30074214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
